Inhibition of growth and linoleate-enhanced metastasis of a transplantable mouse mammary tumor by indomethacin

Research output: Contribution to journalArticlepeer-review

58 Scopus citations


The influence of the cyclo-oxygenase inhibitor, indomethacin (IM), on the metastasis, development and prostaglandin E (PGE) levels of line 4526 mammary tumors grown in mice fed high fat (HF, 20%, w w) diets containing various levels of linoleic acid (18:2) was investigated. Control mice that grew primary tumors and were fed HF diets containing 12% 18:2 ( w w) had 2-3 times the number of lung metastases than mice fed 1%, 4%, or 8% 18:2. Chronic treatment of mice with 10 μg/ml IM in drinking water reduced metastasis in 1% and 4% 18:2-fed mice compared to controls and completely inhibited the increased metastasis of mice fed the 12% 18:2 diet. Treatment with IM also increased the latency and decreased the growth rates of primary 4526 tumors of all dietary groups. Treatment of mice with a higher dosage of IM (20 μg/ml), decreased tumor metastasis even further compared to controls, but did not decrease tumor growth rate compared to the lower dosage of IM (10 μg/ml). Tumor PGE levels, measured by radioimmunoassay (RIA), were decreased by IM treatment. These data provide evidence that arachidonic acid metabolites such as PGE may be involved in the metastasis of 4526 mammary tumors.

Original languageEnglish (US)
Pages (from-to)111-120
Number of pages10
JournalCancer Letters
Issue number1-2
StatePublished - Dec 1 1988


  • indomethacin
  • linoleate enhancement
  • prostaglandin E levels
  • transplantable mouse mammary tumor metastasis

ASJC Scopus subject areas

  • Cancer Research
  • Molecular Biology
  • Oncology


Dive into the research topics of 'Inhibition of growth and linoleate-enhanced metastasis of a transplantable mouse mammary tumor by indomethacin'. Together they form a unique fingerprint.

Cite this